Skip to main content
. 2021 Apr 21;2:100024. doi: 10.1016/j.fochms.2021.100024

Fig. 2.

Fig. 2

Treatment concentration–response curves for ellagic acid using CyQUANT® NF Cell Proliferation Assay expressed as percentage viable intestinal and liver cells remaining after 2 h treatment compared to the HBSS control in (A) Undifferentiated Caco-2, (B) Differentiated Caco-2, (C) HT29-MTX-E12 and (D) HepG2. The data is presented as the mean percentage (±SEM) of six replicates for each treatment.